5854
0
07.05.2020 GILD Daily Analysis
An emergency authorization was given to Gilead Sciences, Inc. (NASDAQ: GILD) by the FDA for its coronavirus treatment candidate redeliver.
Yazar: editor_1
Yayınlanma: 7 Mayıs 2020 19:41
Güncellenme: 13 Kasım 2024 19:57
07.05.2020 GILD Daily Analysis
An emergency authorization was given to Gilead Sciences, Inc. (NASDAQ: GILD) by the FDA for its coronavirus treatment candidate redeliver. The company is going through the confusion on whether to mass-produce the drug or license the drug. Gilead Sciences Inc (GILD) down by -1.67, or by -2.11% at $77.47. Gilead Sciences said Tuesday it will join with other drugmakers to manufacture and sell its Covid-19 treatment remdesivir outside of the U.S., farming out production of the medicine to ensure supply meets global demand.İLGİLİ HABERLER
European stocks soared and focus shifted to German retail sales after Powell's speech!
Forex Signal For TRY/USD: Inflation Slowdown in November.
Forex Signal For GBP/USD: Bullish Trend Still Not Breaking While Recovery Continues.
Forex Signal For EUR/USD: Starry US Data Points to Higher Fed Increases.
Forex Signal For BTC/USD: Downside Continues as Bitcoin Recovery Moves Less.
En Popüler Haberler
Yorum Yap
Yorumlar
Henüz yorum yapan yok! İlk yorumu siz yapın...